Morgan Stanley’s WisdomTree BioRevolution Fund WDNA Stock Holding History

Morgan Stanley’s Portfolio WDNA Stock Details WDNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-1	Closed	-$21	–	8600
2026 Q1	$21	Buy	+1	New	+$18	﹤0.01%	8165
2025 Q4	–	Sell	-1	Closed	-$28	–	8483
2025 Q3	$28	Hold	1	–	–	﹤0.01%	7997
2025 Q2	$19	Sell	1 -126	-99%	-$1.6K	﹤0.01%	8002
2025 Q1	$1.63K	Hold	127	–	–	﹤0.01%	7211
2024 Q4	$1.83K	Buy	127 +2	+2%	+$31	﹤0.01%	7214
2024 Q3	$2.07K	Hold	125	–	–	﹤0.01%	7129
2024 Q2	$1.97K	Buy	+125	New	+$2K	﹤0.01%	7070

Other funds holding WDNA

NBC Securities Birmingham, Alabama $1.48B AUM 31.07% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Morgan Stanley's WDNA Position: Q2 2026 in Review

Morgan Stanley sold out of WisdomTree BioRevolution Fund (WDNA) in Q2 2026, closing a stake of 1 share — an estimated $21 sold.

Morgan Stanley first reported a position in WDNA in Q2 2024 and held it in 7 quarters. The position peaked at $2.07K in Q3 2024. 3 funds tracked by Wall St. Rank hold WDNA as of Q2 2026.

Morgan Stanley reported no remaining WisdomTree BioRevolution Fund position as of Q2 2026 after selling out during the quarter.
Morgan Stanley sold 1 WisdomTree BioRevolution Fund share in Q2 2026, an estimated $21.
Morgan Stanley first reported a position in WisdomTree BioRevolution Fund in Q2 2024 and held it in 7 quarters.
Morgan Stanley's WisdomTree BioRevolution Fund position peaked at $2.07K in Q3 2024.
3 funds tracked by Wall St. Rank held WisdomTree BioRevolution Fund as of Q2 2026.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.